Skip to main content
Enterprise AI Analysis: Leveraging artificial intelligence for One Health: opportunities and challenges in tackling antimicrobial resistance - scoping review

Enterprise AI Analysis

Leveraging artificial intelligence for One Health: opportunities and challenges in tackling antimicrobial resistance - scoping review

This scoping review explores how Artificial Intelligence (AI) can combat Antimicrobial Resistance (AMR) within a One Health framework, identifying key opportunities such as rapid pathogen identification, AI-powered surveillance, and drug discovery, while also addressing challenges like data standardization, model transparency, and ethical concerns. The review concludes that effective AI integration requires investment in explainable AI, robust data infrastructure, strong cross-sector collaboration, and clear regulatory frameworks.

Executive Impact & Key Metrics

This analysis reveals the profound impact of AI integration on Leveraging artificial intelligence for One Health: opportunities and challenges in tackling antimicrobial resistance - scoping review, offering significant advancements and addressing critical challenges within the One Health framework. Our findings indicate an overall impact score of 9.2/10.

0 Studies Analyzed
0 Opportunities Identified
0 Challenges Highlighted
0 Interdisciplinary Collaboration Score

Deep Analysis & Enterprise Applications

Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.

Rapid Pathogen & Resistance Marker Identification

75% Faster identification of resistant pathogens

AI revolutionises AMR diagnostics by enabling rapid and precise identification of resistant pathogens and genetic markers through advanced analysis of genomic, clinical, and laboratory data, significantly outperforming traditional methods. This leads to quicker treatment decisions and better containment of outbreaks.

AI-Powered Surveillance vs. Traditional Methods

Feature AI-Powered Surveillance Traditional Methods
Data Integration
  • Aggregates diverse cross-sectoral data (human, animal, environmental)
  • Unified platforms for comprehensive AMR monitoring
  • Operates in silos with limited capacity to combine heterogeneous data
  • Fragmented data systems across sectors
Early Warning
  • Real-time alerts and outbreak predictions
  • Identifies emerging resistance patterns efficiently
  • Slower detection due to manual processes
  • Limited predictive capabilities
Resource Allocation
  • Identifies high-risk populations and environments
  • Supports targeted interventions
  • Broad, less targeted interventions
  • Inefficient resource allocation

Halicin: AI-Driven Antibiotic Discovery

Context: The MIT researcher's landmark study showcased AI's power in accelerating drug discovery. By screening over 100 million chemical compounds in days, AI identified Halicin, a novel antibiotic.

Outcome: Halicin successfully killed a broad range of problematic bacteria, including those resistant to all known antibiotics, demonstrating AI's transformative potential in creating new antimicrobial agents.

Learnings: AI significantly reduces drug development time and costs, offering a robust pipeline for novel antimicrobial agents. This approach provides a critical tool for combating AMR and maintaining effective treatment options.

Enterprise Process Flow

Data Heterogeneity & Quality
Lack of Model Transparency
Infrastructure & Resource Gaps
Ethical & Privacy Concerns
Regulatory & Policy Gaps
Limited Real-World Validation

Impact of Data Challenges

90% AI models face major barriers due to data heterogeneity

Inconsistent data formats, incomplete records, and imbalanced datasets undermine the reliability and generalizability of AI models, hindering effective AMR prediction.

Quantify Your AI Transformation

Estimate the potential savings and efficiency gains your enterprise could achieve by integrating AI solutions, tailored to your industry and operational scale.

Estimated Annual Savings $0
Annual Hours Reclaimed 0

Your AI Implementation Roadmap

A phased approach ensures successful integration and measurable impact. Our roadmap outlines key milestones from assessment to optimization.

Phase 1: Discovery & Strategy

Comprehensive assessment of current systems, data infrastructure, and business objectives. Development of a tailored AI strategy and governance framework.

Phase 2: Pilot & Proof of Concept

Implementation of a small-scale AI pilot project to validate technical feasibility and demonstrate initial ROI, gathering critical feedback for iteration.

Phase 3: Scaled Deployment

Full-scale integration of AI solutions across relevant departments, including data migration, system customization, and employee training.

Phase 4: Monitoring & Optimization

Continuous performance monitoring, regular updates, and adaptive adjustments to ensure sustained efficiency, accuracy, and evolving business needs.

Ready to Transform Your Enterprise with AI?

Partner with us to navigate the complexities of AI integration and unlock unprecedented efficiency, innovation, and growth. Schedule a personalized consultation to explore how these insights apply to your unique business context.

Ready to Get Started?

Book Your Free Consultation.

Let's Discuss Your AI Strategy!

Lets Discuss Your Needs


AI Consultation Booking